Japanese drugmaker #AsahiKasei has agreed to buy German biotech #Aicuris and its #antiviraltherapy to tackle an infection that can afflict people who undergo a #bonemarrowtransplant.
pharmaphorum.com/news/asahi-k...
0
0
0
0